171 related articles for article (PubMed ID: 31655714)
21. Treatment of diabetes mellitus using an external insulin pump in clinical practice.
Jeandidier N; Riveline JP; Tubiana-Rufi N; Vambergue A; Catargi B; Melki V; Charpentier G; Guerci B
Diabetes Metab; 2008 Sep; 34(4 Pt 2):425-38. PubMed ID: 18951117
[TBL] [Abstract][Full Text] [Related]
22. Continuous subcutaneous insulin infusion therapy and multiple daily insulin injections in type 1 diabetes mellitus: a comparative overview and future horizons.
Thabit H; Hovorka R
Expert Opin Drug Deliv; 2016; 13(3):389-400. PubMed ID: 26618219
[TBL] [Abstract][Full Text] [Related]
23. Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective.
Roze S; Smith-Palmer J; Valentine WJ; Cook M; Jethwa M; de Portu S; Pickup JC
J Med Econ; 2016; 19(3):236-42. PubMed ID: 26510389
[TBL] [Abstract][Full Text] [Related]
24. [From insulin pump and continuous glucose monitoring to the artificial pancreas].
Apablaza P; Soto N; Codner E
Rev Med Chil; 2017 May; 145(5):630-640. PubMed ID: 28898340
[TBL] [Abstract][Full Text] [Related]
25. Continuous subcutaneous insulin infusion (CSII) pumps.
Valla V
Adv Exp Med Biol; 2012; 771():414-9. PubMed ID: 23393693
[TBL] [Abstract][Full Text] [Related]
26. Comparison of flash glucose monitoring with real time continuous glucose monitoring in children and adolescents with type 1 diabetes treated with continuous subcutaneous insulin infusion.
Massa GG; Gys I; Bevilacqua E; Wijnands A; Zeevaert R
Diabetes Res Clin Pract; 2019 Jun; 152():111-118. PubMed ID: 31121275
[TBL] [Abstract][Full Text] [Related]
27. Continuous subcutaneous insulin infusion for managing diabetes: women's health implications.
Hood DG
Nurs Womens Health; 2012; 16(4):308-18. PubMed ID: 22900807
[TBL] [Abstract][Full Text] [Related]
28. Neonatal diabetes and insulin pump therapy.
Beardsall K; Pesterfield CL; Acerini CL
Arch Dis Child Fetal Neonatal Ed; 2011 May; 96(3):F223-4. PubMed ID: 21115555
[TBL] [Abstract][Full Text] [Related]
29. Should Continuous Subcutaneous Insulin Infusion (CSII) Pumps Be Used During the Perioperative Period? Development of a Clinical Decision Algorithm.
Rotruck LS; Suszan LL; Vigersky R; Rotruck CJ; Brown C; Capacchione J; Todd LA
AANA J; 2018 Jun; 86(3):194-200. PubMed ID: 31580807
[TBL] [Abstract][Full Text] [Related]
30. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
Bode BW
Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
[TBL] [Abstract][Full Text] [Related]
31. Consensus Statement on Use of Continuous Subcutaneous Insulin Infusion Therapy in the Hospital.
Thompson B; Korytkowski M; Klonoff DC; Cook CB
J Diabetes Sci Technol; 2018 Jul; 12(4):880-889. PubMed ID: 29681173
[TBL] [Abstract][Full Text] [Related]
32. Restoring euglycemia in the basal state using continuous glucose monitoring in subjects with type 1 diabetes mellitus.
Zisser HC; Bevier WC; Jovanovic L
Diabetes Technol Ther; 2007 Dec; 9(6):509-15. PubMed ID: 18034605
[TBL] [Abstract][Full Text] [Related]
33. Approach to the adult hospitalized patient on an insulin pump.
Lansang MC; Modic MB; Sauvey R; Lock P; Ross D; Combs P; Kennedy L
J Hosp Med; 2013 Dec; 8(12):721-7. PubMed ID: 24227761
[TBL] [Abstract][Full Text] [Related]
34. Education for continuous subcutaneous insulin infusion pump users.
American Association of Diabetes Educators
Diabetes Educ; 2003; 29(1):97-9. PubMed ID: 12645494
[TBL] [Abstract][Full Text] [Related]
35. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients.
Nathan DM; Dunn FL; Bruch J; McKitrick C; Larkin M; Haggan C; Lavin-Tompkins J; Norman D; Rogers D; Simon D
Am J Med; 1996 Apr; 100(4):412-7. PubMed ID: 8610727
[TBL] [Abstract][Full Text] [Related]
36. Insulin pump use compared with intravenous insulin during labour and delivery: the INSPIRED observational cohort study.
Drever E; Tomlinson G; Bai AD; Feig DS
Diabet Med; 2016 Sep; 33(9):1253-9. PubMed ID: 26927202
[TBL] [Abstract][Full Text] [Related]
37. Glucose profiles in a type 1 diabetic patient successively treated with CSII using regular insulin, lispro and an implantable insulin pump.
Catargi B; Breilh D; Roger P; Tabarin A
Diabetes Metab; 2000 May; 26(3):210-4. PubMed ID: 10880895
[TBL] [Abstract][Full Text] [Related]
38. A Technological Revolution: The Integration of New Treatments to Manage Type 1 Diabetes.
Galderisi A; Sherr JL
Pediatr Ann; 2019 Aug; 48(8):e311-e318. PubMed ID: 31426099
[TBL] [Abstract][Full Text] [Related]
39. Comparison of continuous subcutaneous insulin infusion and multiple daily insulin injections in Chinese patients with type 2 diabetes mellitus.
Yang H; Heng X; Liang C; Liu X; Du W; Li S; Wang Y; Dong Q; Li W; Pan Z; Gong Q; Gao G
J Int Med Res; 2014 Aug; 42(4):1002-10. PubMed ID: 24965335
[TBL] [Abstract][Full Text] [Related]
40. Successful treatment of young infants presenting neonatal diabetes mellitus with continuous subcutaneous insulin infusion before genetic diagnosis.
Rabbone I; Barbetti F; Marigliano M; Bonfanti R; Piccinno E; Ortolani F; Ignaccolo G; Maffeis C; Confetto S; Cerutti F; Zanfardino A; Iafusco D
Acta Diabetol; 2016 Aug; 53(4):559-65. PubMed ID: 26831749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
